Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease.
作者信息
Ludgate M, Baker G
机构信息
Department of Medicine, University of Wales College of Medicine, Cardiff, UK.
出版信息
Clin Exp Immunol. 2002 Feb;127(2):193-8. doi: 10.1046/j.1365-2249.2002.01792.x.
Abstract
摘要
相似文献
1
Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease.
Clin Exp Immunol. 2002 Feb;127(2):193-8. doi: 10.1046/j.1365-2249.2002.01792.x.
2
Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.
Endocrinology. 2005 Feb;146(2):835-44. doi: 10.1210/en.2004-1015. Epub 2004 Nov 11.
3
Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
Clin Exp Immunol. 2018 Mar;191(3):255-267. doi: 10.1111/cei.13075. Epub 2017 Nov 17.
4
Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease.
J Clin Invest. 2000 Mar;105(6):803-11. doi: 10.1172/JCI7665.
5
Animal model of thyroid-associated orbitopathy.
Exp Clin Endocrinol Diabetes. 1999;107 Suppl 5:S158-9. doi: 10.1055/s-0029-1212174.
6
Development of an animal model of autoimmune thyroid eye disease.
J Immunol. 1999 Apr 15;162(8):4966-74.
7
Unique properties of orbital connective tissue underlie its involvement in Graves' disease.
Minerva Endocrinol. 2003 Sep;28(3):213-22.
8
Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice.
Clin Exp Immunol. 2003 Feb;131(2):234-40. doi: 10.1046/j.1365-2249.2003.02080.x.
9
Autoimmune endocrine diseases.
Year Immunol. 1989;4:264-75.
10
A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity.
Br Med J (Clin Res Ed). 1984 Apr 21;288(6425):1183-6. doi: 10.1136/bmj.288.6425.1183.
引用本文的文献
1
Inflammatory profiling and immune cell infiltration in dysthyroid optic neuropathy: insights from bulk RNA sequencing.
Front Immunol. 2025 Mar 12;16:1550694. doi: 10.3389/fimmu.2025.1550694. eCollection 2025.
2
Hashimoto's Thyroiditis and Dry Eye Disease.
J Clin Med. 2025 Mar 4;14(5):1710. doi: 10.3390/jcm14051710.
3
Serum PD-1 regulation and PD-1 expression of CD4+Foxp3+ regulatory T cells in patients in thyroid eye disease associated with immunosuppression treatment.
Front Ophthalmol (Lausanne). 2024 Dec 16;4:1491053. doi: 10.3389/fopht.2024.1491053. eCollection 2024.
4
The Relevance and Potential Role of Orbital Fat in Inflammatory Orbital Diseases: Implications for Diagnosis and Treatment.
Ophthalmol Ther. 2025 Feb;14(2):247-281. doi: 10.1007/s40123-024-01079-7. Epub 2024 Dec 16.
5
Immune Checkpoints and Graves' Disease, Thyroid Eye Disease, and Orbital Myopathy: A Comprehensive Review.
J Ophthalmic Vis Res. 2024 Sep 16;19(3):368-380. doi: 10.18502/jovr.v19i3.15047. eCollection 2024 Jul-Sep.
6
Effect of orbital decompression surgery on the choroidal profile in patients with thyroid eye disease.
Sci Rep. 2024 Jun 28;14(1):14948. doi: 10.1038/s41598-024-65884-7.
7
Statins and thyroid eye disease (TED): a systematic review.
Endocrine. 2024 Jul;85(1):11-17. doi: 10.1007/s12020-023-03680-5. Epub 2024 Jan 9.
8
Morbihan disease misdiagnosed as senile blepharoptosis and successfully treated with short-term minocycline and ketotifen: A case report.
World J Clin Cases. 2023 Jul 6;11(19):4692-4697. doi: 10.12998/wjcc.v11.i19.4692.
9
Cytokines as Targets of Novel Therapies for Graves' Ophthalmopathy.
Front Endocrinol (Lausanne). 2021 Apr 16;12:654473. doi: 10.3389/fendo.2021.654473. eCollection 2021.
10
Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance.
Br J Radiol. 2021 Feb 1;94(1118):20200884. doi: 10.1259/bjr.20200884. Epub 2020 Dec 22.
本文引用的文献
1
Adipogenesis in thyroid eye disease.
Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3249-55.
2
Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy.
Clin Exp Immunol. 2000 Sep;121(3):453-7. doi: 10.1046/j.1365-2249.2000.01335.x.
3
Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking.
Eur J Endocrinol. 2000 Aug;143(2):197-202. doi: 10.1530/eje.0.1430197.
4
Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts.
Am J Physiol Cell Physiol. 2000 Aug;279(2):C335-40. doi: 10.1152/ajpcell.2000.279.2.C335.
5
Soluble interleukin-1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoids.
Clin Endocrinol (Oxf). 2000 May;52(5):647-51. doi: 10.1046/j.1365-2265.2000.00988.x.
6
Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease.
J Clin Invest. 2000 Mar;105(6):803-11. doi: 10.1172/JCI7665.
7
Cultured human fibroblasts express constitutive IL-16 mRNA: cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism.
J Immunol. 2000 Apr 1;164(7):3806-14. doi: 10.4049/jimmunol.164.7.3806.
8
Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy.
J Clin Endocrinol Metab. 2000 Mar;85(3):1194-9. doi: 10.1210/jcem.85.3.6433.
9
Relationship between disease duration and predominant orbital T cell subset in Graves' ophthalmopathy.
J Clin Endocrinol Metab. 2000 Feb;85(2):776-80. doi: 10.1210/jcem.85.2.6333.
10
The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy.
Thyroid. 1999 Dec;9(12):1175-80. doi: 10.1089/thy.1999.9.1175.
Zotero 插件